Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-24100

ABSTRACT: Isolation and characterization of cancer-associated fibroblast-like cells in the glioblastoma microenvironment

OTHER RELATED OMICS DATASETS IN: PRJNA130303

DISEASE(S): Control,Glioblastoma

PROVIDER: E-GEOD-24100 | ExpressionAtlas | 2025-01-24

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-GEOD-24100-analysis-methods.tsv	Tabular
	E-GEOD-24100-atlasExperimentSummary.Rdata	Rdata
	E-GEOD-24100-configuration.xml	Xml
	E-GEOD-24100-percentile-ranks.tsv	Tabular
	E-GEOD-24100.condensed-sdrf.tsv	Tabular

Items per page:

1 - 5 of 44

Similar Datasets

Homo sapiens

Project description:Isolation and characterization of cancer-associated fibroblast-like cells in the glioblastoma microenvironment

| PRJNA130303 | ENA

Uncovering glioblastoma origin cells: Isolation and characterization from the subventricular zone

Project description:Uncovering glioblastoma origin cells: Isolation and characterization from the subventricular zone

| PRJNA1285712 | ENA

Characterization of WDR5 WIN-site Inhibition in Two Glioblastoma Cancer Stem Cell Models using Bulk RNAseq

Project description:WDR5 inhibitors have been implicated as a therapeutic vulnerability in glioblastoma cancer stem cells (CSCs). We tested the transcriptional effects of two different WDR5 WIN-site inhibitors, the dihydroisoquinoline C16 and the triazole C3TD078, in two CSC models (L0 and DI318) by bulk RNAseq.These data are associated with Coker et al., "Development and Characterization of Triazole-Based WDR5 Inhibitors for the Treatment of Glioblastoma," bioRxiv, 2025, https://doi.org/10.1101/2025.07.29.667410.

2025-08-15 | GSE304999 | GEO

Mapping the chemotherapy-induced RNA interactome in Glioblastoma [smallRNA-Seq]

Project description:Long non-coding RNAs (lncRNAs) are increasingly recognized as important players in transcription and epigenetic-driven cell diversification. So far, lncRNA function in more dynamic transcriptional reprogramming, i.e drug response, has been largely unexplored. Here, we investigated the regulatory circuits induced by chemotherapy in glioblastoma, the most aggressive and clinically refractory brain cancer. We performed a detailed characterization of the cellular and transcriptional response of glioblastoma stem-like cells to the alkylating agent temozolomide (TMZ). We found that in addition to mRNAs, TMZ affects the expression of a large number of non-coding RNAs (miRNAs, snoRNAs, lncRNAs). Our global transcriptome analysis provides a comprehensive characterization of regulatory circuits involving transcription factors, mRNAs, miRNAs and lncRNAs. To analyse the putative functions of these largely unknown RNA molecules, we developed a pipeline to integrate small and large RNA-seq data from multiple public databases and our own experiments. This led to the identification of the RNA interactome of glioblastoma and allowed us to define regulatory loops mediated by lncRNAs. We identified 22 key lncRNAs involved in transcriptional regulatory motifs, and three lncRNAs associated with patient prognosis, independent of other known response predictors. The investigation of TMZ-induced molecular networks in glioblastoma highlights novel coding and non-coding RNA-based predictors of glioblastoma chemoresistance, as well as potential targets to counteract such resistance.

2019-04-24 | GSE98127 | GEO

Homo sapiens

Project description:Isolation and genomic characterization of cancer stem cells in head and neck cancer

| PRJNA239762 | ENA

Abernathy2016 - glioblastoma treatment

Project description:The paper describes a model of glioblastoma. Created by COPASI 4.25 (Build 207) This model is described in the article: Modeling the Treatment of Glioblastoma Multiforme and Cancer Stem Cells with Ordinary Differential Equations Kristen Abernathy and Jeremy Burke BMC Computational and Mathematical Methods in Medicine Volume 2016, Article ID 1239861, 11 pages Abstract: Despite improvements in cancer therapy and treatments, tumor recurrence is a common event in cancer patients. One explanation of recurrence is that cancer therapy focuses on treatment of tumor cells and does not eradicate cancer stem cells (CSCs). CSCs are postulated to behave similar to normal stem cells in that their role is to maintain homeostasis. That is, when the population of tumor cells is reduced or depleted by treatment, CSCs will repopulate the tumor, causing recurrence. In this paper, we study the application of the CSC Hypothesis to the treatment of glioblastoma multiforme by immunotherapy. We extend the work of Kogan et al. (2008) to incorporate the dynamics of CSCs, prove the existence of a recurrence state, and provide an analysis of possible cancerous states and their dependence on treatment levels. To cite BioModels Database, please use: BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models . To the extent possible under law, all copyright and related or neighbouring rights to this encoded model have been dedicated to the public domain worldwide. Please refer to CC0 Public Domain Dedication for more information.

2024-09-02 | BIOMD0000000757 | BioModels

MIRO2-mediated mitochondrial transfer from cancer cells induces cancer-associated fibroblast differentiation

Project description:MIRO2-mediated mitochondrial transfer from cancer cells induces cancer-associated fibroblast differentiation

| PRJNA1113323 | ENA

Glutathione S-transferase omega class 1 (GSTO1)-associated large extracellular vesicles involves in tumor-associated macrophage-mediated cisplatin resistance in bladder cancer

Project description:Proteomic characterization of bladder cancer cells exposed to medium from tumor-associated macrophages cocultured with bladder cancer cells.

2025-02-20 | PXD049719 | JPOST Repository

glioblastoma and glioblastoma stem cells (GSCs), RNA-seq and WGS

Project description:Characterization of glioblastoma tumors and glioblastoma stem cells (GSCs) lines via RNA-seq and/or WGS profiling.

| EGAS00001004395 | EGA

To find out different expression lncRNAs between glioblastoma cancer and adjacent normal glioblastoma tissue

Project description:To further understand the molecular mechanisms in the development of glioblastoma cancer, we employed this microarray to identify lncRNAs associated with glioblastoma cancer.

2016-06-21 | GSE83511 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data